ProfessorMolly Stevens, FREng FRS

Overview

Professor Dame Molly Stevens is an international leader in ground-breaking biosensing technologies, transformative regenerative medicine and advanced therapeutics approaches; has published extensively (over 400 papers and H-index over 100) in leading journals such as Science, Nature, Nature Nanotechnology and Nature Materials; and was named a Clarivate Analytics Highly Cited Researcher in Cross-Field Research. She is a serial entrepreneur and has significant expertise in commercialisation of devices, with numerous patents filed and 4 spin-out companies based on her research.

Professor Dame Molly Stevens’ research programme uses innovative bioengineering approaches to pursue the vision of solving key problems in regenerative medicine, biosensing and therapeutics. The Stevens Group’s biomaterial innovations are also applied to soft robotics, and to the interface between living and non-living matter, and are underpinned by collaborations with molecular dynamics experts and data scientists in the digital health field. This work is inherently interdisciplinary, so the Stevens Group is made up of a diverse cast of materials scientists, engineers, chemists, biologists, physicists and surgeons.

For up to date PICTURES and BACKGROUNDS and listing of GROUP MEMBERS and overview of our research see our group website.
***Several PhD and postdoctoral positions in Tissue Engineering and Nanomaterials/Bio-Nanotechnology available - please get in touch for vacancies.***